698 A.2d 959 (Del. Ch. 1996)
In re Caremark International Inc. Derivative Litigation is a landmark case in corporate law that addresses the duties of directors in overseeing corporate compliance and risk management.
Did the board of directors of Caremark International Inc. breach their fiduciary duty of care by failing to establish adequate oversight and compliance mechanisms?
The legal principle established in Caremark is that directors of a corporation have a duty to exercise good faith and due care in overseeing the company's operations and compliance with laws. This includes the obligation to implement a system of internal controls and to monitor the company's compliance with applicable laws and regulations. The court articulated that a failure to act in good faith or to establish such oversight can lead to liability for directors if it results in harm to the corporation.
The Delaware Court of Chancery held that the directors of Caremark did not breach their fiduciary duties. The court found that while the directors had failed to establish a comprehensive compliance program, the plaintiffs did not demonstrate that this failure amounted to a lack of good faith or that it caused the alleged harm to the corporation. The court emphasized that the directors had taken some steps to monitor compliance, and thus, their actions did not rise to the level of a breach of duty.
The significance of In re Caremark extends beyond its immediate holding, as it has become a cornerstone case in corporate governance and director liability. The case established a framework for evaluating the oversight duties of directors, emphasizing the need for proactive compliance measures and the importance of good faith in fulfilling fiduciary responsibilities. This case has influenced subsequent rulings and has been cited in numerous cases addressing director oversight and compliance issues.